786 followers
Similar efficacy of golimumab in <65 year olds vs >=65s with #rheumatoidarthritis. Not convinced that safety is merely "numerically" worse in elderly. Serious AEs in 18% vs 25% despite trial patients being relatively healthy (without comorbidities).